Paula Sweeney has been chosen as one of D Magazine’s 2016 “Best Lawyers in Dallas” in the Tort Product and Medical Liability Litigation (plaintiff) category. After tallying thousands of votes cast by her peers, the magazine assembled a panel of esteemed counselors to review the list, which ultimately included 695 lawyers. The list will be published in D Magazine’s May 2016 issue. Congratulations, Paula!
How many fatalities, or near fatalities, need to occur before a medical product manufacturer takes the faulty product off the market? Apparently no benchmark has been put to the test, as is the case with C.R. Bard’s Recovery inferior vena cava (IVC) filter. The device, implanted in patients who are at risk for blood clots, is now associated with at least 27 deaths over a 10-year period, leading to many lawsuits. Continue reading
In early June 2015, Smith & Nephew, a multinational medical equipment manufacturer, issued a medical device alert stating that certain groups of patients with the Birmingham Hip™ Resurfacing (BHR) implant system are at a higher risk of revision compared to the other groups. Continue reading
In one of the largest national landmark settlements, the global medical devices and equipment manufacturing company, Stryker Corp., will pay out $1.43 billion to patients who had hip implant revision surgery to remove defective Rejuvenate or ABG II Modular-Neck Hip Stems. It is imperative for any victim who suffers serious injury or illness from the surgical installment of these hip implants get help right away, and secure their legal rights for compensation. Continue reading
Yesterday, the Wall Street Journal reported that Johnson & Johnson is withdrawing laparoscopic power morcellators that can spread cancer in women, which effectively removes the device’s largest manufacturer from the market. This decision comes after the debate over the tool agitated the gynecological field for months. Continue reading